Diabetes Clinical Trials in Nashville

Showing 241-260 of 299 trials

Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT)

NCT00889785

The proposed research will test a new comprehensive disease management intervention with adolescents who have type 2 diabetes using a randomized controlled trial (RCT). Adolescents subjects with a history of Type 2 Diabetes and a parent caregiver will be consented, enrolled, and randomly assigned to either an 6-month intervention (N=44) or a "usual care" comparison (N=44). Recruitment will take place within the Vanderbilt Eskind Pediatric Diabetes Clinic. The intervention will include participation in a comprehensive disease management program that includes: (1) application of treatment algorithms, (2) phone assessment from a diabetes nurse practitioner and dietician to assess barriers and promote problem solving, treatment adherence and management, and (3) a behavioral Internet-administered self-management problem solving component. Outcomes include self-reported self-management behaviors (exercise, diet, medication adherence, etc.), blood pressure, weight/BMI, and glycated hemoglobin (A1C).

Adolescents With Type 2 Diabetes

Vanderbilt University43 participantsStarted Jun 2009

Nashville, Tennessee, United States

COMPLETEDPHASE3100 miles

Dapagliflozin DPPIV Inhibitor add-on Study

NCT00984867

This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.

Type 2 Diabetes

AstraZeneca833 participantsStarted Oct 2009

Huntsville, Alabama, United States • Ozark, Alabama, United States • Anaheim, California, United States +85 more locations

Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT)

Dapagliflozin DPPIV Inhibitor add-on Study

Diabetes Trials in Other Cities

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Screening for Early Evidence of Diabetes

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Diabetes and Periodontal Therapy Trial

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Other Conditions in Nashville